Porous poly(ε-caprolactone) scaffolds for retinal pigment epithelium transplantation

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 3, 2014, Pages 1754-1762

  McHugh, Kevin J ^a,b,c   Tao, Sarah L ^c   Saint Geniez, Magali ^a,d  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c CHARLES STARK DRAPER LABORATORY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Age related macular degeneration; In vitro; Porous polycaprolactone; Retinal pigment epithelium; Scaffold

Indexed keywords

MOLECULAR SCAFFOLD; PIGMENT EPITHELIUM DERIVED FACTOR; POLYCAPROLACTONE; POROUS POLYMER; VASCULOTROPIN;

ARTICLE; CELL CULTURE; CELL DENSITY; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PHAGOCYTOSIS; PIGMENT EPITHELIUM; POROSITY; PRIORITY JOURNAL; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; RETINA MACULA AGE RELATED DEGENERATION; TRANSEPITHELIAL ELECTRICAL RESISTANCE; TRANSPLANTATION;

AGE-RELATED MACULAR DEGENERATION; IN VITRO; POROUS POLYCAPROLACTONE; RETINAL PIGMENT EPITHELIUM; SCAFFOLD;

CELLS, CULTURED; HUMANS; MACULAR DEGENERATION; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; POLYESTERS; POROSITY; RETINAL PIGMENT EPITHELIUM; TISSUE SCAFFOLDS;

EID: 84896913925     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12833     Document Type: Article

References (56)

1. Jager RD, Mieler WF, Miller JW. Age-related macular degeneration. N Engl J Med. 2008;358:2606-2617.
2. Nowak JZ. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep. 2006;58:353-363.
3. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev. 2005;85:845-881.
4. Binder S, Stanzel BV, Krebs I, Glittenberg C. Transplantation of the RPE in AMD. Prog Retin Eye Res. 2007;26:516-554.
5. Shiragami C, Matsuo T, Shiraga F, Matsuo N. Transplanted and repopulated retinal pigment epithelial cells on damaged Bruch's membrane in rabbits. Br J Ophthalmol. 1998;82: 1056-1062.
6. Ramrattan RS, van der Schaft TL, Mooy CM, de Bruijn WC, Bulder PG, de Jong PT. Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. Invest Ophthalmol Vis Sci. 1994;35:2857-2864.
7. Moore DJ, Hussain AA, Marshall J. Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci. 1995;36:1290-1297.
8. Curcio CA, Johnson M. Structure, function, and pathology of Bruch's membrane. In: Ryan SJ, ed. Retina: Expert Consult Premium Edition. Oxford: Elsevier;2013;465-481.
9. Pauleikhoff D, Harper CA, Marshall J, Bird AC. Aging changes in Bruch's' membrane. A histochemical and morphologic study. Ophthalmology. 1990;97:171-178.
10. Marshall GE, Konstas AG, Reid GG, Edwards JG, Lee WR. Type IV collagen and laminin in Bruch's membrane and basal linear deposit in the human macula. Br J Ophthalmol. 1992;76:607-617.
11. Tezel TH, Kaplan HJ, Del Priore LV. Fate of human retinal pigment epithelial cells seeded onto layers of human Bruch's membrane. Invest Ophthalmol Vis Sci. 1999;40:467-476.
12. Tezel TH, Del Priore LV. Repopulation of different layers of host human Bruch's membrane by retinal pigment epithelial cell grafts. Invest Ophthalmol Vis Sci. 1999;40:767-774.
13. Cai H, Del Priore LV. Bruch membrane aging alters the gene expression profile of human retinal pigment epithelium. Curr Eye Res. 2006;31:181-189.
14. Sun K, Cai H, Tezel TH, Paik D, Gaillard ER, Del Priore LV. Bruch's membrane aging decreases phagocytosis of outer segments by retinal pigment epithelium. Mol Vis. 2007;13: 2310-2319.
15. Gullapalli VK, Sugino IK, Van Patten Y, Shah S, Zarbin MA. Impaired RPE survival on aged submacular human Bruch's membrane. Exp Eye Res. 2005;80:235-248.
16. Hynes SR, Lavik EB. A tissue-engineered approach towards retinal repair: scaffolds for cell transplantation into the subretinal space. Graefes Arch Clin Exp Ophthalmol. 2010; 248:763-778.
17. Del Priore LV, Tezel TH, Kaplan HJ. Survival of allogeneic porcine retinal pigment epithelial sheets after subretinal transplantation. Invest Ophthalmol Vis Sci. 2004;45:985-992.
18. Giordano GG, Thomson RC, Ishaug SL, et al. Retinal pigment epithelium cells cultured on synthetic biodegradable polymers. J Biomed Mater Res. 1997;34:87-93.
19. Singh S, Woerly S, McLaughlin BJ. Natural and artificial substrates for retinal pigment epithelial monolayer transplantation. Biomaterials. 2001;22:3337-3343.
20. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol. 2005;23:47-55.
21. Lu L, Mikos AG. The importance of new processing techniques in tissue engineering. MRS Bull. 1996;21:28-32.
22. Saint-Geniez M, Tao SL, Tucker BT, et al. Retina reconstruction. In: Ducheyne P, Healy K, Hutmacher DE, Grainger DW, Kirkpatrick CJ, eds. Comprehensive Biomaterials. Waltham, MA: Elsevier; 2011;500-516.
23. Liu X, Holzwarth JM, Ma PX. Functionalized synthetic biodegradable polymer scaffolds for tissue engineering. Macromol Biosci. 2012;12:911-919.
24. Thomson HA, Treharne AJ, Walker P, Grossel MC, Lotery AJ. Optimisation of polymer scaffolds for retinal pigment epithelium (RPE) cell transplantation. Br J Ophthalmol. 2011;95: 563-568.
25. Gunatillake PA, Adhikari R. Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater. 2003;5:1-16.
26. Christiansen AT, Tao SL, Smith M, et al. Subretinal implantation of electrospun, short nanowire, and smooth poly(ε-caprolactone) scaffolds to the subretinal space of porcine eyes. Stem Cells Int. 2012;2012:454295.
27. Sabir MI, Xu X, Li L. A review on biodegradable polymeric materials for bone tissue engineering applications. J Mater Sci. 2009;44:5713-5724.
28. Kohn J, Abramson S, Langer R. Bioresorbable and bioerodible materials. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, eds. Biomaterials Science: An Introduction to Materials in Medicine. 2nd ed. Boston, MA: Elsevier Academic Press; 2004; 115-126.
29. Tao S, Young C, Redenti S, et al. Survival, migration and differentiation of retinal progenitor cells transplanted micromachined poly(methyl methacrylate) scaffolds to the subretinal space. Lab Chip. 2007;7:695-701.
30. Montezuma SR, Loewenstein J, Scholz C, Rizzo JF 3rd. Biocompatibility of materials implanted into the subretinal space of Yucatan pigs. Invest Ophthalmol Vis Sci. 2006;47: 3514-3522.
31. Redenti S, Tao S, Yang J, et al. Retinal tissue engineering using mouse retinal progenitor cells and a novel biodegradable, thinfilm poly(e-caprolactone) nanowire scaffold. J Ocul Bio Dis Infor. 2008;1:19-29.
32. Redenti S, Neeley WL, Rompani S, et al. Engineering retinal progenitor cell and scrollable poly(glycerol-sebacate) composites for expansion and subretinal transplantation. Biomaterials. 2009;30:3405-3414.
33. Pachence JM, Bohrer MP, Kohn J. Biodegradable polymers. In: Lanza R, Langer R, Vacanti J, eds. Principles of Tissue Engineering. 3rd ed. Burlington, MA: Elsevier Academic Press; 2007;323-340.
34. Salgado CL, Sanchez EM, Zavaglia CA, Granja PL. Biocompatibility and biodegradation of polycaprolactone-sebacic acid blended gels. J Biomed Mater Res A. 2012;100:243-251.
35. McHugh KJ, Tao SL, Saint-Geniez M. Topographical control of ocular cell types for tissue engineering. J Biomed Mater Res B. 2013;doi: 10.1002/jbm.b.32968.
36. McHugh KJ, Tao SL, Saint-Geniez M. A novel porous scaffold fabrication technique for epithelial and endothelial tissue engineering. J Mater Sci Mater Med. 2013;24:1659-1670.
37. Tsang SH, Burns ME, Calvert PD, et al. Role for the target enzyme in deactivation of photoreceptor G protein in vivo. Science. 1998;282:117-121.
38. Quinn JA, Anderson JL, Ho WS, Petzny WJ. Model pores of molecular dimension: the preparation and characterization of track-etched membranes. Biophys J. 1972;12:990-1007.
39. Blaauwgeers HG, Holtkamp GM, Rutten H, et al. Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am J Pathol. 1999;155: 421-428.
40. Maminishkis A, Chen S, Jalickee S, et al. Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest Ophthalmol Vis Sci. 2006;47:3612-3624.
41. Polyak SL. The Retina. Chicago: University of Chicago Press; 1941.
42. Young RW. The renewal of rod and cone outer segments in the rhesus monkey. J Cell Biol. 1971;49:303-318.
43. Vaajasaari H, Ilmarinen T, Juuti-Uusitalo K, et al. Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells. Mol Vis. 2011;17:558-575.
44. Marmor MF. Retinal pigment epithelium. Yanoff M, Duker JS, eds. Ophthalmology: Expert Consult Premium Edition. 3rd ed. Oxford: Mosby Elsevier; 2008:515-517.
45. Kokkinopoulos I, Shahabi G, Colman A, Jeffery G. Mature peripheral RPE cells have an intrinsic capacity to proliferate; a potential regulatory mechanism for age-related cell loss. PLoS One. 2011;6:e18921.
46. Panda-Jonas S, Jonas JB, Jakobczyk-Zmija M. Retinal pigment epithelial cell count, distribution, and correlations in normal human eyes. Am J Ophthalmol. 1996;121:181-189.
47. Del Priore LV, Kuo YH, Tezel TH. Age-related changes in human RPE cell density and apoptosis proportion in situ. Invest Ophthalmol Vis Sci. 2002;43:3312-3318.
48. Newsome DA, Dobard EP, Liles MR, Oliver PD. Human retinal pigment epithelium contains two distinct species of superoxide dismutase. Invest Ophthalmol Vis Sci. 1990;31:2508-2513.
49. Ablonczy Z, Dahrouj M, Tang PH, et al. Human retinal pigment epithelium cells as functional models for the RPE in vivo. Invest Ophthalmol Vis Sci. 2011;52:8614-8620.
50. McKay BS, Goodman B, Falk T, Sherman SJ. Retinal pigment epithelial cell transplantation could provide trophic support in Parkinson's disease: results from an in vitro model system. Exp Neurol. 2006;201:234-243.
51. Suzuki F, Kubota T, Miyazaki Y, et al. Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity. Arthritis Res Ther. 2012;14:R48.
52. Takahashi K, Ohara M, Sasai T, et al. Serum CXCL1 concentrations are elevated in type 1 diabetes mellitus, possibly reflecting activity of anti-islet autoimmune activity. Diabetes Metab Res Rev. 2011;27:830-833.
53. Cao S, Walker GB, Wang X, Cui JZ, Matsubara JA. Altered cytokine profiles of human retinal pigment epithelium: oxidant injury and replicative senescence. Mol Vis. 2013;19: 718-728.
54. Nagineni CN, Kutty V, Detrick B, Hooks JJ. Expression of PDGF and their receptors in human retinal pigment epithelial cells and fibroblasts: regulation by TGF-beta. J Cell Physiol. 2005; 203:35-43.
55. Moore DJ, Clover GM. The effect of age on the macromolecular permeability of human Bruch's membrane. Invest Ophthalmol Vis Sci. 2001;42:2970-2975.
56. Zayas-Santiago A, Marmorstein AD, Marmorstein LY. Relationship of Stokes radius to the rate of diffusion across Bruch's membrane. Invest Ophthalmol Vis Sci. 2011;52:4907-4913.